Vanguard Group Inc Cryo Cell International Inc Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Cryo Cell International Inc stock. As of the latest transaction made, Vanguard Group Inc holds 114,779 shares of CCEL stock, worth $729,994. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,779
Previous 92,939
23.5%
Holding current value
$729,994
Previous $693,000
25.97%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CCEL
# of Institutions
16Shares Held
916KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$2.61 Million2.55% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$1.05 Million0.97% of portfolio
-
Massmutual Trust CO Fsb111KShares$706,1820.03% of portfolio
-
Geode Capital Management, LLC Boston, MA23.7KShares$150,4580.0% of portfolio
-
Northern Trust Corp Chicago, IL22.2KShares$141,1790.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $54.2M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...